Alexis Peyroles

Alexis Peyroles

Chief Executive Officer chez Ose Immunotherapeutics, Inc.

Fortune : 5 M $ au 31/03/2024

Health Technology
Consumer Services
Distribution Services

Profil

Alexis Peyroles currently works at Ose Immunotherapeutics, Inc., as Chief Executive Officer and Aperana Consulting SAS, as Chairman.
Mr. Peyroles also formerly worked at OSE Immunotherapeutics SA, as Chief Executive Officer & Director from 2018 to 2022, Guerbet Imagem do Brasil Ltda., as Chief Executive Officer, Guerbet SA, as Manager-Financial Control, Sanofi-Aventis Japan, as Head-Financial Control-Baltic States, Sanofi-Aventis France SA, as Head-Eastern Europe Business Development, and Orphan Synergy Europe-Pharma SA, as CFO & Head-Business Development.
Mr. Peyroles received his undergraduate degree from École des Hautes Études Commerciales du Nord and Masters Business Admin degree from Imperial College Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2022 929 862 ( 4,27% ) 5 M $ 31/03/2024

Postes actifs de Alexis Peyroles

SociétésPosteDébut
Aperana Consulting SAS Chairman -
Ose Immunotherapeutics, Inc. Chief Executive Officer -
Tous les postes actifs de Alexis Peyroles

Anciens postes connus de Alexis Peyroles

SociétésPosteFin
OSE IMMUNOTHERAPEUTICS Chief Executive Officer 16/01/2022
Guerbet Imagem do Brasil Ltda. Chief Executive Officer -
Sanofi-Aventis Japan Comptroller/Controller/Auditor -
GUERBET Comptroller/Controller/Auditor -
Corporate Officer/Principal -
Voir l'expérience en détail de Alexis Peyroles

Formation de Alexis Peyroles

École des Hautes Études Commerciales du Nord Undergraduate Degree
Imperial College Business School Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Alexis Peyroles

Relations

20

Relations au 1er degré

10

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
GUERBET

Health Technology

OSE IMMUNOTHERAPEUTICS

Health Technology

Entreprise privées6
Sanofi-Aventis Japan

Distribution Services

Health Technology

Aperana Consulting SAS

Ose Immunotherapeutics, Inc.

Guerbet Imagem do Brasil Ltda.

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Alexis Peyroles